Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|December 28, 2020
Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAsHiroko Sakuma, Shinji Hagiwara, Phillip Kantharidis, et al.
Clinical Science (London, England : 1979)|November 7, 2019
Specialized pro-resolving mediators in diabetes: novel therapeutic strategiesEoin P Brennan, Muthukumar Mohan, Darrell Andrews, et al.
Molecular and Cellular Biology|February 28, 2002
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activationAssam El-Osta, Phillip Kantharidis, John R Zalcberg, et al.
International Journal of Molecular Sciences|January 23, 2024
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney DiseaseShinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, et al.
Current Drug Targets|January 19, 2012
Advanced glycation end products as environmental risk factors for the development of type 1 diabetesFelicia Y T Yap, Phillip Kantharidis, Melinda T Coughlan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Regulation of MDR1 gene expression: emerging conceptsPhillip Kantharidis, Sam El-Osta, Michelle de Silva, et al.
The Journal of Biological Chemistry|February 18, 2011
TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4Catherine E Winbanks, Bo Wang, Claudia Beyer, et al.
Frontiers in Physiology|January 9, 2019
The Use of Targeted Next Generation Sequencing to Explore Candidate Regulators of TGF-β1's Impact on Kidney CellsBo Wang, Guanyu Ji, Haroon Naeem, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
The role of advanced glycation in reduced organic cation transport associated with experimental diabetesMerlin C Thomas, Christos Tikellis, Phillip Kantharidis, et al.
Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.
Pageof 5